Mapsonib 200mg Tablet

About

Mapsonib, representative of a Tyrosine Kinase Inhibitor (TKI), is a class of targeted therapy drugs revolutionizing cancer treatment. TKIs operate by specifically blocking the activity of aberrant tyrosine kinases, which are enzymes that play critical roles in cell signaling pathways responsible for cancer cell growth, proliferation, survival, and metastasis. In many cancers, these kinases are overactive or mutated, driving uncontrolled cell division. By precisely inhibiting these specific molecular targets, Mapsonib can effectively disrupt the signaling cascades that fuel tumor progression, leading to a more selective anti-cancer effect compared to conventional chemotherapy. This targeted approach often results in improved efficacy and a more favorable side effect profile for patients with specific types of cancer, such as chronic myeloid leukemia, gastrointestinal stromal tumors, and certain lung cancers.

Uses

• Treatment of chronic myeloid leukemia (CML).
• Treatment of gastrointestinal stromal tumors (GIST).
• Treatment of certain types of lung cancer.
• Treatment of renal cell carcinoma.

Directions For Use

Take this medicine exactly as prescribed by your doctor, usually once daily. It can be taken with or without food, depending on the specific TKI.

Benefits

• Targets specific cancer pathways.
• Effective against various solid and hematologic tumors.
• Often leads to durable responses.
• Improves progression-free survival.
• Can be used as monotherapy.
• Available in convenient oral tablet form.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Rash
• Fluid retention (edema)
• Muscle cramps
• Headache
• Bone marrow suppression (low blood counts)
• Liver enzyme elevation
• Hypertension
• Cardiac dysfunction (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol as it may exacerbate gastrointestinal side effects and liver strain.
• Pregnancy - Contraindicated in pregnancy due to potential harm to the fetus. Use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and harm the infant.
• Liver - Use with caution in liver impairment; requires regular monitoring of liver function tests.
• Kidney - Dose adjustments may be necessary in kidney impairment; close monitoring is essential.
• Lung - Rarely, can cause interstitial lung disease or pneumonitis; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.